EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Olfactory Function as a Candidate Endpoint of Type 2 (Th2) Inflammation: Translational Rationale from Humans to Dogs

Alessandro Serrone, Giovanni Cavallo, Gian Luca Fadda, Alessandro Marzolla, Andrea Serrone, Lorenzo Migliore, Giorgia Cavallo, Chiara Rustichelli

Allergies · 21.05.2026 · 6 (2) · 19

DOI: 10.3390/allergies6020019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergies, online erschienen am 21.05.2026. Verfasst von Alessandro Serrone und 7 weiteren Autor:innen. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 inflammation is a central immunopathogenic driver of chronic immune-mediated disease, characterized by IgE polarization, eosinophilia, epithelial barrier disruption, and tissue remodeling. In veterinary medicine, especially in canine atopic and allergic disorders, the absence of validated functional endpoints hampers disease monitoring and therapeutic assessment. In humans, this endotype underlies a spectrum of linked conditions, including asthma, allergic rhinitis, atopic dermatitis, and chronic rhinosinusitis with nasal polyps (CRSwNP), where olfactory dysfunction is common, quantifiable, and clinically meaningful. In this narrative review, we examine the relationship between type 2 inflammation and olfactory outcomes in human disease and consider its translational relevance in dogs within a reverse translational One Health framework. Evidence from human studies, particularly in CRSwNP, shows a strong association between type 2 inflammatory burden and olfactory loss, while biologics targeting these pathways yield clinically meaningful gains in smell function. Comparable clinical evidence is still lacking in dogs. Olfactory function should therefore be regarded as a promising, yet unvalidated, translational endpoint in canine type 2 disease and a priority for prospective clinical investigation and methodological validation.

Zitieren

APA

Serrone, A., Cavallo, G., Fadda, G. L., Marzolla, A., Serrone, A., Migliore, L., Cavallo, G., & Rustichelli, C. (2026). Olfactory Function as a Candidate Endpoint of Type 2 (Th2) Inflammation: Translational Rationale from Humans to Dogs. Allergies, 6(2), 19. https://doi.org/10.3390/allergies6020019

Vancouver

Serrone A, Cavallo G, Fadda GL, Marzolla A, Serrone A, Migliore L, et al. Olfactory Function as a Candidate Endpoint of Type 2 (Th2) Inflammation: Translational Rationale from Humans to Dogs. Allergies. 2026;6(2):19. doi:10.3390/allergies6020019

BibTeX
@article{Serrone2026,
  author = {Serrone, Alessandro and Cavallo, Giovanni and Fadda, Gian Luca and Marzolla, Alessandro and Serrone, Andrea and Migliore, Lorenzo and Cavallo, Giorgia and Rustichelli, Chiara},
  title = {Olfactory Function as a Candidate Endpoint of Type 2 (Th2) Inflammation: Translational Rationale from Humans to Dogs},
  journal = {Allergies},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {19},
  doi = {10.3390/allergies6020019}
}
Kostenlos starten →